Concept to launch packaging steps, from first concept to approved pack

Gianni Linssen
Written by
Gianni Linssen
/ Published on
August 18, 2026
Learn the key packaging steps from concept to launch in pharma, from artwork and braille checks to trials, change control, and release readiness.
A pristine unbranded pharmaceutical carton with tablets and a leaflet, styled for a premium magazine.

Concept-to-launch packaging steps encompass the checks, owners, and approval points that move a pack from an early idea to launch readiness. In the pharmaceutical industry, teams often plan dates but overlook the critical work required between them. This gap typically involves artwork rounds, braille, readability, leaflet fit, samples, line trials, and late changes. If these steps remain unclear, projects frequently face obsolete files, incorrect components, production holds, and launch delays.

• This article highlights the tasks teams often forget to schedule between concept and launch.

• Each section outlines who typically takes action, what must be checked, and what can go wrong if a step is missed.

• This guide is designed to be highly practical, allowing project managers to use it as a comprehensive packaging project checklist.

• The list is not exhaustive for every product or market, as packaging requirements vary by product, pack type, and country.

Why concept-to-launch packaging steps often fail between teams

This article is fundamentally different from a timeline guide. While a timeline answers how long specific work may take, this guide addresses what teams frequently forget to plan during packaging development. This distinction is crucial because the pharmaceutical packaging process often fails during handoffs rather than at main milestones. For a wider background on the broader process, explore pharmaceutical packaging development.

Many delays begin when one team assumes a task is already underway, while another believes it starts later. Consequently, ownership remains vague and review points stay open. The result is straightforward: the project moves forward while hidden packaging work is left behind. This guide helps teams identify who owns each task, determine what must be checked, and understand what might happen if a step is skipped.

Although the examples provided here are common, they do not serve as a definitive rulebook for every product or market. Regulatory needs, pack formats, and local requirements can vary significantly. Nevertheless, the control points outlined below often determine whether launch work remains stable or begins to drift late in the project.

Concept-to-launch packaging steps for artwork rounds and controlled review

Plan the second and third artwork rounds

Many teams plan for only one review round, expecting the file to close quickly. In reality, the second and third reviews often resolve the most critical issues. Feedback may come from regulatory, quality, medical, brand, packaging, and local market reviewers. These comments must follow a single shared route, as a minor text change can significantly affect the layout, code space, leaflet references, or other elements of the pack.

A robust artwork approval process includes clear dates, designated reviewers, and specific decision rules for each round. Without this structure, comments frequently arrive late or in the wrong order. This can lead to a cycle where one correction creates another, leaving the team with unapproved artwork just when production requires the final file.

Keep one controlled version for all reviewers

Every reviewer must work from the same controlled version. If one person comments on an outdated PDF while another uses a newer file, the team risks approving two different iterations without noticing the conflict. A single accountable artwork approver should maintain ownership of the current version, the review status, and the final release route.

While this step may seem like basic administrative work, it is actually a core control point. It protects the project from conflicting feedback, obsolete files, and ambiguous approval statuses. That is precisely why it belongs firmly inside the concept-to-launch packaging steps plan rather than on the periphery.

What happens if review rounds are skipped

Skipping review rounds often leads to late corrections, incorrect print files, and unexpected production holds. A printer or packing site might begin preparing materials from a file that subsequently changes. As a result, valuable time is lost, and launch stock may fall behind schedule. In many projects, what starts as a minor issue quickly escalates because multiple teams are already working from an earlier version.

Concept-to-launch packaging steps for braille and readability checks

Schedule the braille packaging check where needed

When applicable, a braille packaging check should be scheduled as a distinct task. A designated individual must confirm the text, language, placement, and whether the braille can be effectively embossed on the final pack. Depending on the company structure and supplier setup, ownership of this task might sit within regulatory affairs, packaging engineering, artwork, or quality assurance.

Since the need for braille depends heavily on the product and target market, teams should never leave this requirement unaddressed until late in the project. For deeper insights, read about braille on medicine packaging. The crucial element here is timing; the check must happen early enough to make necessary pack adjustments before formal release work begins.

Treat readability as a separate patient review

The readability of medicine packaging is entirely distinct from artwork accuracy. A pack can display the correct text yet still be difficult for patients or caregivers to navigate. Therefore, readability must have its own dedicated owner, timing, and formal review point. Teams should verify whether vital information is easy to locate, simple to read, and perfectly clear during typical use.

This review should be conducted early enough to successfully refine the final carton, leaflet, and printed instructions. If it happens too late, the team might realize the pack is difficult to use but be unable to improve it without extensive rework. Discover more about best practices surrounding medicine packaging readability.

Concept-to-launch packaging steps for market variants and leaflet feasibility

Map market-specific variants early

Market-specific packaging variants should be carefully mapped before any artwork is considered final. A designated owner must manage country-specific text, symbols, coding, pack sizes, and any approved differences between markets. When ownership is unclear, a single base pack can easily fracture into multiple versions without adequate oversight.

These regional variations impact artwork, component counts, reconciliation logic, and inventory planning. Without a clear variant map, teams may order the wrong components, duplicate efforts, or manufacture an incorrect launch combination. While this issue might seem minor initially, it can quickly become costly when physical stock, digital files, and launch plans no longer align.

Check leaflet insertion feasibility before final artwork release

The feasibility of leaflet insertion should be thoroughly confirmed prior to final artwork release. The packaging engineer and the packer must evaluate the final page count, paper behavior, fold pattern, folded dimensions, and available carton space. A leaflet might look perfect on a computer screen but still fail completely on the physical packing line.

If teams skip this crucial check, they may discover too late that the leaflet folds poorly, fails to fit into the carton, or jams during the packing process. Consequently, the project might suddenly require a revised fold pattern, a larger carton, or a delayed artwork update. This represents a remarkably common source of delays, as the problem usually surfaces right after the team believes the design has been finalized.

Concept-to-launch packaging steps for sample approval, line trials, and release readiness

Define formal packaging sample approval

Packaging sample approvals should always be formalized and fully documented. The project manager must define exactly who will review product fit, physical appearance, instructions, tamper evidence, opening features, and overall handling. All comments, final decisions, and the approved version must be recorded to ensure that subsequent discussions do not inadvertently reopen a sample that was already accepted.

Informal sample approvals often fail because later reviewers were excluded from the process, or the team simply cannot demonstrate which sample was actually approved. Therefore, sample reviews must be scheduled as clear, rigid control points rather than casual sign-offs conducted via email or basic meeting notes.

Treat tooling and component lead times as planned work

Tooling and component lead times require dedicated space in the project plan right from the start. They are a fundamental part of packaging readiness, as early design choices directly dictate when parts can be manufactured, tested, and approved for use. When teams treat this work as a purely procurement-driven activity, the launch plan might appear complete while critical materials are, in fact, still missing.

This dynamic impacts cartons, inserts, trays, blisters, labels, custom tooling parts, and various other printed or formed components. A single late design decision can dramatically shift several supply dates at once. To avoid this, teams must connect their technical choices with accurate delivery timelines as early as possible.

Set line trial acceptance criteria before the trial starts

A line trial is truly useful only if the team agrees beforehand on what a successful result looks like. The acceptance criteria should clearly cover product damage limits, machine feeding, forming, sealing integrity, print positioning, folding accuracy, coding, and overall inspection performance at a practical level. By establishing these metrics early, the trial outcome can be judged objectively, and open action items can be recorded in an actionable format.

If a trial begins without mutually agreed-upon criteria, participants frequently walk away with conflicting views of success. Unresolved problems then cascade into later qualification stages or even into the first commercial batch. By that point, any necessary changes are significantly harder to manage and exponentially more costly to correct.

Map execution needs before packing starts

The designated packer should be deeply involved before any final design decisions are made, as real-world line limitations dictate what can be run in a fully controlled manner. Carton formats, leaflet designs, coding setups, component supply chains, and inspection methods all heavily influence successful execution. To assess this stage proactively, review how preparation and execution connect through secondary contract packaging readiness.

Partnering with an external packing facility does not absolve a company of its approval duties or release responsibilities. Final sign-off stays firmly with the customer, and QA authority remains governed by the customer internal quality system. Early input from the packer simply makes hidden work visible before commercial packing starts, allowing teams to correct operational issues while multiple options remain viable.

When approved packaging changes late

Use packaging change control for any approved element that shifts

Late changes are an inevitable part of real-world projects. Whenever an approved element shifts, the packaging change control process must review its impact on product quality, regulatory status, artwork files, physical components, and the overall schedule. Without this comprehensive review, one part of the project might move forward while another mistakenly adheres to an earlier version.

This disconnect typically results in mismatched documents and materials. For example, revised text might successfully make it into the new artwork file, yet the printed physical stock, line instructions, or packaging batch records may still display the previous iteration. Therefore, every late-stage change requires one clear route, named owners, and a formally documented impact check.

Review the first batch record before launch release

Reviewing the first batch record should be deliberately planned well before launch release, rather than acting as a frantic discovery step at the very end. This review confirms whether the packaging instructions, printed codes, physical components, and documented controls perfectly match the approved pack and intended packing method. It also highlights operational gaps that may have remained hidden during early development or initial trial work.

Quality assurance maintains release responsibility entirely within the customer quality system. This mandate must remain absolutely clear throughout the lifespan of the project. While external partners can help make the underlying work visible across concept, components, packaging, and execution, the customer release authority and final sign-off responsibilities never transfer.

A practical packaging project checklist for concept-to-launch packaging steps

Questions to ask before final launch readiness

Use this targeted packaging project checklist before giving final approval and beginning the supply chain flow. The goal is straightforward: every single item must have a clear owner, a defined status, and documented evidence of completion. If even one answer is vague, a significant risk is likely hiding in the space between teams, suppliers, or critical documents.

• Who ultimately owns final artwork approval, and are all reviewers reliably using the exact same controlled version?

• Has the braille packaging check been confirmed where applicable, and has medicine packaging readability been reviewed as an entirely separate patient-focused task?

• Are all market-specific packaging variants fully mapped and approved, and has leaflet insertion feasibility been successfully confirmed on the intended packing line?

• Has packaging sample approval been formally documented, and are all tooling and component delivery dates explicitly embedded in the project schedule?

• Are the line trial criteria firmly agreed upon, is the packaging change control system ready to handle late updates, and has the first batch record review been strategically planned?

If you can answer each of these questions with a clear owner and a current status, your packaging readiness for launch is typically very strong. However, if several points remain unclear, late corrections and highly avoidable delays often follow because crucial hidden work has yet to be completed.

Next steps for teams wanting to test launch readiness

If this checklist reveals open action points within your project, you can easily start a packaging quickscan to assess your current concept, artwork, and production line status. This process helps make critical collaborative work completely visible across concept, components, packaging, and execution, all while your team confidently retains ownership of approvals, sign-offs, and final release decisions.

FAQ

What are concept-to-launch packaging steps in pharma? They are the deliberately planned packaging tasks that bridge the gap between an early concept and final launch readiness. This critical phase includes structured review rounds, strict file control, braille verification, readability checks, mapping market variants, leaflet feasibility assessments, sample approvals, line trials, formal change control, and complete release preparation.

Why do packaging launch delays often happen late? Delays typically surface late in the process because the underlying missed work occurred much earlier. A skipped review round, an unclear task owner, or an unverified supplier check can easily remain hidden until production, validation, or first batch planning ultimately brings the issue to light.

Who should own these packaging checks? While specific ownership depends heavily on the company internal structure, it must always be explicitly assigned. Project managers typically coordinate the overarching plan, whereas regulatory, quality assurance, packaging engineering, artwork management, local market teams, and external packing partners each own their clearly defined review points.

Is this checklist sufficient for every product and market? No. It serves as a highly practical guide for mitigating common launch risks, but different products, pack formats, and countries will naturally dictate unique requirements. Teams should carefully adapt this checklist to suit their specific product, chosen route to market, and overarching quality system.

Request a free sample now!

Ecobliss Pharmaceutical cold seal wallet
Do you want to experience first hand the usability and quality of our packaging solutions? We'll send you one!
Request the free sample!
This might also interest you:
See all blog posts
Icon arrow

Contact the team

Our team is fine blend of knowledge, experience and eagerness. Give them a call. Or send a message to call you back at a convenient time for you.
Gianni Linssen

Gianni Linssen

+31625517974
Timo Kubbinga

Timo Kubbinga

+31627348895
Jaime Wauben

Jaime Wauben

+31615446090

Or send a message

Thank you! Your submission has been sent! I'll contact you soon.
Oops! Something went wrong while submitting the form.
Sample Request
Quickscan
Schedule a meeting

One moment please, loading calendar...

Schedule a meeting
Icon calendarClose icon